Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News MASTERCARD INCORPORATED MA

Alternate Symbol(s):  N.MA | MA.29A

Mastercard is the second- largest payment processor in the world, having processed close to $6 trillion in purchase transactions during 2021. Mastercard operates in over 200 countries and processes transactions in over 150 currencies.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NYSE:MA)

Fundamentals Snapshot (NYSE:MA)

Opinion & Analysis (NYSE:MA)

A Surprising Buffett ETF

Benzinga.com  August 11, 2015

Why credit card companies are still soaring (MA) (V)

Dr. Steve Sjuggerud June 16, 2015

Lone Pine Capital Shuffles Its Top 5 Positions

Benzinga.com  May 18, 2015

MasterCard (MA): Can it charge past short-term resistance?

Elizabeth Harrow and Andrea Kramer September 16, 2010

Why economic shrinkage is a good thing

Timothy Lutts December 8, 2008

Bullboard Posts (NYSE:MA)

Mobile Payment Market Report 2022-27: Industry Trends, Share

The IMARC Group provides extensive analysis of the mobile payment industry covering the market trends, investment opportunities...
edwardebreen15 - 2 days ago

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

 
SallySa - July 15, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >> FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets...
SallySa - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

SallySa - June 2, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

 
SallySa - May 11, 2022

Lucid-MS for Multiple Sclerosis Treatment

<< View Post To Watch Video >>
SallySa - May 3, 2022